vs
Amarin Corp plc（AMRN）与i3 Verticals, Inc.（IIIV）财务数据对比。点击上方公司名可切换其他公司
i3 Verticals, Inc.的季度营收约是Amarin Corp plc的1.2倍（$52.7M vs $45.1M），i3 Verticals, Inc.净利率更高（0.9% vs -23.3%，领先24.2%），Amarin Corp plc同比增速更快（7.0% vs -14.6%），过去两年i3 Verticals, Inc.的营收复合增速更高（-4.7% vs -18.3%）
Amarin是一家1993年成立的爱裔美籍生物制药企业，总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物，已推出处方级Omega-3脂肪酸药物Vascepa（AMR-101）。
Prusa i3是捷克Prusa Research公司生产的熔融沉积成型3D打印机系列，以Original Prusa i3为注册商标推出，同时也是RepRap项目的组成部分。2016年该系列就被评为全球使用率最高的3D打印机，最早由Josef Průša在2012年完成设计，2015年正式推出商用套件版本，目前最新型号同时提供散件套件和原厂组装版本，具备性价比高、易操作的优势。
AMRN vs IIIV — 直观对比
营收规模更大
IIIV
是对方的1.2倍
$45.1M
营收增速更快
AMRN
高出21.6%
-14.6%
净利率更高
IIIV
高出24.2%
-23.3%
两年增速更快
IIIV
近两年复合增速
-18.3%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $52.7M |
| 净利润 | $-10.5M | $484.0K |
| 毛利率 | — | — |
| 营业利润率 | 35.5% | 3.1% |
| 净利率 | -23.3% | 0.9% |
| 营收同比 | 7.0% | -14.6% |
| 净利润同比 | 33.0% | -76.5% |
| 每股收益（稀释后） | — | $0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRNIIIV
| Q1 26 | $45.1M | — | ||
| Q4 25 | $49.2M | $52.7M | ||
| Q3 25 | $49.7M | $46.0M | ||
| Q2 25 | $72.7M | $51.9M | ||
| Q1 25 | $42.0M | $63.1M | ||
| Q4 24 | $62.3M | $52.2M | ||
| Q3 24 | $42.3M | $32.0M | ||
| Q2 24 | $67.5M | $46.2M |
净利润AMRNIIIV
| Q1 26 | $-10.5M | — | ||
| Q4 25 | $-1.2M | $484.0K | ||
| Q3 25 | $-7.7M | $3.1M | ||
| Q2 25 | $-14.1M | $12.9M | ||
| Q1 25 | $-15.7M | $-154.0K | ||
| Q4 24 | $-48.6M | $2.1M | ||
| Q3 24 | $-25.1M | $117.9M | ||
| Q2 24 | $1.5M | $-7.5M |
毛利率AMRNIIIV
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | — | ||
| Q3 25 | 44.7% | — | ||
| Q2 25 | 69.2% | — | ||
| Q1 25 | 59.8% | — | ||
| Q4 24 | -15.4% | — | ||
| Q3 24 | 38.5% | — | ||
| Q2 24 | 63.4% | — |
营业利润率AMRNIIIV
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | 3.1% | ||
| Q3 25 | -22.4% | 3.2% | ||
| Q2 25 | -22.0% | -9.3% | ||
| Q1 25 | -39.9% | 8.0% | ||
| Q4 24 | -84.3% | 3.9% | ||
| Q3 24 | -59.5% | 10.6% | ||
| Q2 24 | -0.8% | -2.8% |
净利率AMRNIIIV
| Q1 26 | -23.3% | — | ||
| Q4 25 | -2.5% | 0.9% | ||
| Q3 25 | -15.6% | 6.7% | ||
| Q2 25 | -19.4% | 24.8% | ||
| Q1 25 | -37.4% | -0.2% | ||
| Q4 24 | -78.0% | 3.9% | ||
| Q3 24 | -59.4% | 368.2% | ||
| Q2 24 | 2.3% | -16.3% |
每股收益（稀释后）AMRNIIIV
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | $0.02 | ||
| Q3 25 | $-0.02 | $0.14 | ||
| Q2 25 | $-0.03 | $0.50 | ||
| Q1 25 | $-0.04 | $0.00 | ||
| Q4 24 | $-0.12 | $0.08 | ||
| Q3 24 | $-0.06 | $4.93 | ||
| Q2 24 | $0.00 | $-0.32 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | $37.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $358.5M |
| 总资产 | $645.8M | $595.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AMRNIIIV
| Q1 26 | $307.8M | — | ||
| Q4 25 | $302.6M | $37.5M | ||
| Q3 25 | $286.6M | $66.7M | ||
| Q2 25 | $298.7M | $55.5M | ||
| Q1 25 | $281.8M | $7.7M | ||
| Q4 24 | $294.2M | $85.6M | ||
| Q3 24 | $305.7M | $86.5M | ||
| Q2 24 | $306.7M | $9.7M |
总债务AMRNIIIV
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $0 | ||
| Q2 25 | — | $0 | ||
| Q1 25 | — | $12.0M | ||
| Q4 24 | — | $26.2M | ||
| Q3 24 | — | $26.2M | ||
| Q2 24 | — | $374.1M |
股东权益AMRNIIIV
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | $358.5M | ||
| Q3 25 | $458.9M | $389.6M | ||
| Q2 25 | $464.9M | $383.3M | ||
| Q1 25 | $473.7M | $385.2M | ||
| Q4 24 | $486.2M | $375.0M | ||
| Q3 24 | $531.4M | $379.7M | ||
| Q2 24 | $551.9M | $249.7M |
总资产AMRNIIIV
| Q1 26 | $645.8M | — | ||
| Q4 25 | $670.8M | $595.9M | ||
| Q3 25 | $659.8M | $638.4M | ||
| Q2 25 | $670.1M | $623.3M | ||
| Q1 25 | $655.7M | $646.4M | ||
| Q4 24 | $685.3M | $726.2M | ||
| Q3 24 | $750.6M | $730.7M | ||
| Q2 24 | $799.9M | $861.7M |
负债/权益比AMRNIIIV
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.07× | ||
| Q3 24 | — | 0.07× | ||
| Q2 24 | — | 1.50× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $14.1M |
| 自由现金流经营现金流 - 资本支出 | — | $13.8M |
| 自由现金流率自由现金流/营收 | — | 26.2% |
| 资本支出强度资本支出/营收 | — | 0.6% |
| 现金转化率经营现金流/净利润 | — | 29.18× |
| 过去12个月自由现金流最近4个季度 | — | $6.5M |
8季度趋势，按日历期对齐
经营现金流AMRNIIIV
| Q1 26 | — | — | ||
| Q4 25 | $15.3M | $14.1M | ||
| Q3 25 | $-12.7M | $14.0M | ||
| Q2 25 | $16.6M | $7.4M | ||
| Q1 25 | $-12.5M | $-27.1M | ||
| Q4 24 | $-13.3M | $11.5M | ||
| Q3 24 | $-2.4M | $15.1M | ||
| Q2 24 | $-2.7M | $8.1M |
自由现金流AMRNIIIV
| Q1 26 | — | — | ||
| Q4 25 | — | $13.8M | ||
| Q3 25 | — | $13.5M | ||
| Q2 25 | — | $6.8M | ||
| Q1 25 | — | $-27.6M | ||
| Q4 24 | — | $11.0M | ||
| Q3 24 | — | $14.6M | ||
| Q2 24 | — | $7.2M |
自由现金流率AMRNIIIV
| Q1 26 | — | — | ||
| Q4 25 | — | 26.2% | ||
| Q3 25 | — | 29.5% | ||
| Q2 25 | — | 13.1% | ||
| Q1 25 | — | -43.8% | ||
| Q4 24 | — | 21.1% | ||
| Q3 24 | — | 45.6% | ||
| Q2 24 | — | 15.6% |
资本支出强度AMRNIIIV
| Q1 26 | — | — | ||
| Q4 25 | — | 0.6% | ||
| Q3 25 | — | 0.9% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | — | 0.9% | ||
| Q3 24 | — | 1.7% | ||
| Q2 24 | — | 1.9% |
现金转化率AMRNIIIV
| Q1 26 | — | — | ||
| Q4 25 | — | 29.18× | ||
| Q3 25 | — | 4.52× | ||
| Q2 25 | — | 0.57× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 5.59× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | -1.81× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
IIIV
| License And Service | $35.7M | 68% |
| Proprietary Payments Revenue | $14.5M | 27% |
| Other Revenue | $2.5M | 5% |
